Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
暂无分享,去创建一个
C. Dominici | S. Ceccarelli | H. McDowell | A. Pizzuti | R. Maggio | F. Papaccio | V. Desiderio | V. Tombolini | C. Marchese | F. Megiorni | R. Shukla | G. Gravina | C. Festuccia | S. Camero | F. De Felice | F. Marampon | L. Sanière | P. Pujuguet | A. Del Fattore | Filip Beirinckx | Ellen Van der Aar | Ellen Van der Aar